Hello, Guest!
  • Thursday, April 18, 2024
Don McMaster Director

Don McMaster Named DLH Federal Health Director

Don McMaster, a government health care market veteran, has joined DLH Holdings (Nasdaq: DLHC) as director of the company's federal health group, FedHealthIT reported Friday.

He most recently held a senior director position at Maximus (NYSE: MMS) with responsibility over business development and capture functions within the federal market area.

McMaster also worked as a senior business manager at UnitedHealth Group's (NYSE: UNH) Optum/QSSI organization, where he was responsible for financial project management under the Centers for Medicare and Medicaid Services' marketplace project.

Before that, he spent five years at ICF (Nasdaq: ICFI) and led its health surveillance line of business as a vice president. He also served in VP and technical director roles at Macro International.

DLH acquired Falls Church, Virginia-based Irving Burton Associates earlier this month in a $32M cash transaction as part of federal market push.

Video of the Day

Related Articles

Retired ManTech Exec Judith Bjornaas Joins DLH Board of Directors Executive Moves

Retired ManTech Exec Judith Bjornaas Joins DLH Board of Directors

Judith Bjornaas, former executive vice president and chief financial officer of ManTech, has joined the board of directors at health care and public services provider DLH Holdings (Nasdaq: DLHC). DLH’s board elected Bjornaas during its annual meeting held March 9, the company said Monday. The 38-year financial management veteran of the government services industry recently

DLH Subsidiary to Support National Cancer Institute IT Operations via $1.7B BPA; Zach Parker Quoted Contract Awards

DLH Subsidiary to Support National Cancer Institute IT Operations via $1.7B BPA; Zach Parker Quoted

A DLH Holdings (Nasdaq: DLHC) subsidiary holds a position on a $1.7 billion blanket purchase agreement for information technology services to a National Cancer Institute component. Grove Resource Solutions is among the eight vendors eligible to offer enterprise and IT support for the NCI’s Center for Biomedical Informatics and Information Technology through the five-year, multiple-award

National Cancer Institute Awards 5 Spots on $320M Epidemiology, Genetics Research Contract Contract Awards

National Cancer Institute Awards 5 Spots on $320M Epidemiology, Genetics Research Contract

Three companies and two nonprofit organizations have won spots on a potential 10-year, $320 million contract to support epidemiology and genetics research at the National Cancer Institute. Work under the indefinite-delivery/indefinite-quantity contract involves field preparation, biospecimen collection and clinical assistance to NCI’s Division of Cancer Epidemiology and Genetics, according to an award notice posted on